WEREWOLF THERAPEUTICS INC (HOWL)

US95075A1079 - Common Stock

4.72  -0.16 (-3.28%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-3-31)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
16.22M19.94M16.40M0.000.00
Operating Expenses
61.67M60.45M72.46M50.09M22.40M
Research and Development
42.98M41.78M53.76M35.27M16.64M
Selling, General, and Administrative Expenses
18.69M18.67M18.70M14.82M5.76M
Operating Income
-45.44M-40.50M-56.06M-50.09M-22.40M
Interest Income/Expense
3.90M4.28M1.91M100.00K100.00K
Other Income/Expense
-47.00K-1.14M340.00K0.007.26M
Income Before Taxes
-41.59M-37.37M-53.81M-49.98M-15.04M
Income Tax
N/AN/AN/AN/A0.00
Net Income
-41.59M-37.37M-53.81M-201.93M-28.22M
EBITDA
-43.65M-38.74M-54.96M-49.87M-22.25M
 
Per Share Data
EPS Diluted Total Ops
-1.09-1.05-1.86-7.39-1.02
Non GAAP EPS
-1.09-1.04-1.88-88.35N/A
 
Statistics
Profit Margin
-256.34%-187.37%-328.11%N/AN/A
Operating Profit Margin
-280.12%-203.09%-341.83%N/AN/A

All data in USD

Charts